As of 2025-11-17, the EV/EBITDA ratio of S2Medical AB (publ) (S2M.ST) is -1.64. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. S2M.ST's latest enterprise value is 7.07 mil SEK. S2M.ST's TTM EBITDA according to its financial statements is -4.31 mil SEK. Dividing these 2 quantities gives us the above S2M.ST EV/EBITDA ratio.
| Range | Selected | |
| Trailing P/E multiples | 18.4x - 27.1x | 23.0x |
| Forward P/E multiples | 12.3x - 16.7x | 15.1x |
| Fair Price | (0.09) - 0.15 | 0.01 |
| Upside | -1033.0% - 1350.2% | -27.9% |
| Date | EV/EBITDA |
| 2025-11-14 | -1.64 |
| 2025-11-13 | -1.78 |
| 2025-11-12 | -1.68 |
| 2025-11-11 | -1.72 |
| 2025-11-10 | -1.82 |
| 2025-11-07 | -1.85 |
| 2025-11-06 | -1.93 |
| 2025-11-05 | -1.95 |
| 2025-11-04 | -1.95 |
| 2025-11-03 | -1.99 |
| 2025-10-31 | -2.03 |
| 2025-10-30 | -1.93 |
| 2025-10-29 | -2.03 |
| 2025-10-28 | -1.99 |
| 2025-10-27 | -2.03 |
| 2025-10-24 | -1.99 |
| 2025-10-23 | -1.99 |
| 2025-10-22 | -2.07 |
| 2025-10-21 | -2.03 |
| 2025-10-20 | -2.03 |
| 2025-10-17 | -2.07 |
| 2025-10-16 | -2.05 |
| 2025-10-15 | -2.20 |
| 2025-10-14 | -2.09 |
| 2025-10-13 | -2.09 |
| 2025-10-10 | -2.03 |
| 2025-10-09 | -2.03 |
| 2025-10-08 | -2.05 |
| 2025-10-07 | -1.99 |
| 2025-10-06 | -2.13 |
| 2025-10-03 | -2.09 |
| 2025-10-02 | -2.05 |
| 2025-10-01 | -2.01 |
| 2025-09-30 | -1.99 |
| 2025-09-29 | -1.93 |
| 2025-09-26 | -2.01 |
| 2025-09-25 | -2.01 |
| 2025-09-24 | -1.97 |
| 2025-09-23 | -1.89 |
| 2025-09-22 | -2.01 |
| 2025-09-19 | -2.09 |
| 2025-09-18 | -2.09 |
| 2025-09-17 | -2.09 |
| 2025-09-16 | -2.11 |
| 2025-09-15 | -2.07 |
| 2025-09-12 | -2.11 |
| 2025-09-11 | -2.11 |
| 2025-09-10 | -2.13 |
| 2025-09-09 | -2.11 |
| 2025-09-08 | -2.13 |